Table 6 Percentage of patients by age and sex with cardiovascular disease risk ⩾20% estimated using Framingham and QRISK in the validation cohorts having excluded patients receiving statins at baseline

Age band(years)	QRISK equation		Framingham equation
Age band(years)	In QRESEARCH validation cohort	In THIN validation cohort	In QRESEARCH validation cohort	In THIN validation cohort
Women
35–44	0.00	0.00	0.01	0.01
45–54	0.02	0.01	0.79	0.57
55–64	2.23	1.24	7.33	6.38
65–74	31.43	26.38	24.1	21.67
All women	5.25	4.23	5.35	4.75

Men
35–44	0.00	0.00	0.29	0.22
45–54	0.48	0.24	7.76	7.31
55–64	13.65	10.34	40.75	38.47
65–74	68.9	64.05	86.25	83.78
All men	10.78	9.93	20.01	20.06

All patients aged 35–74	7.99	7.04	12.63	12.31